您现在的位置:2020年香港本港台开码 > 教育科研 > 课改前沿 > 正文内容

Chinese Alzheimers drug to undergo global clinical tris

作者:admin 来源:未知 更新日期:2020-01-22 浏览次数:

  
 

   GengMeiyu(L),keyinventorofthedrugGV-971,alsoaresearcherofShanghaiInstituteofMateriaMedicaunderChineseAcademyofSciences,discussestheresearchprogresswithhercolleagueattheGreenValleyinstituteinShanghai,eastChina,,:XinhuaAninnovativeChineseAlzheimersdrugthathitthedomesticmarketlastweekwillgothroughclinicaltrialson2,inNorthAmerica,theEuropeanUnion,EasternEurope,AsiaPacificandotherplaces,accordingtoGreenValleyPharmaceuticalCo.,Ltd,oneofthedrugndertheChineseAcademyofSciences(CAS),OceanUniversityofChinaandGreenValley,ionaljournalCellResearchinSeptember2019,sayingthatthedrug,extractedfrombrownalgae,worksbymodifyinggutbacteriatoultimatelyreducebrainsNationalMedicalProductsAdministration,whichsaidtheGV-971"canimprovecognitioninpatientswithmildtomoderateAlzheimersdisease(AD)."Accordingtoresearchers,apartfromanimalexperiments,morethan1,100Chinese,atotalof818participantsfrom34leadinghospitalsinChinatook450mgGV-971orallytwiceadayforatreatmentperiodofninemonths,whichprovedsafeandeffectiveinimprovingcognition."BecauseofitseffectivenessonChinesepatients,weexpectthisdrugtobenefitmorepeopleintherestoftheworld,"saidLyuSongtao,ehind60percentto70percentofthecases,,progressivebraindisorderthatslowlydestroysmemory,toincreaseto40millionby2050,morethanthepopulationofCanada,,theaveragespendingcanreach130,000yuan(about18,),580yuan.。

(责任编辑:admin)
【字体: